Chinese medicine exports rise rapidly with the high recognition of local enterprises
Pharmaceutical Network September 25th Chinese medicine exports rapidly rose under the impetus of traditional market demand, and the rise of the world 'Chinese medicine fever' has also stimulated the participation of many countries and new regional demand.
In 2017, China patented drug In the form of extracts and raw materials, 358,000 tons of Chinese medicines were exported, an increase of 0.7% year-on-year. medicine Health care products According to data from the Chamber of Import and Export, the export value of Chinese medicines has now reached US$3.6 billion, an increase of 2.1%.
'Southeast Asian countries have a tradition of using traditional Chinese medicine, and the international demand for Chinese medicine has also been accelerated due to the rise of the world 'Chinese medicine fever'.' Yu Zhibin, director of the Chinese Medicine Department of the Chamber of Commerce, said.
Wang Tao, the head of the overseas business unit of Taiji Group, a leading pharmaceutical company in China, agreed. With the rapid development of China's economy, China's influence in the world is increasing, and Chinese brands are increasingly recognized by the world.
The rise of the 'world's Chinese medicine fever' is particularly helpful for the promotion of Chinese medicine, enabling China to increase exchanges with other regions and giving other regions a deeper understanding of China and Chinese culture.
In 2015, Taiji Group accelerated the global expansion of its business by establishing an overseas business unit. Taiji Group has been closely monitoring the spread of Chinese medicine abroad and the business opportunities brought about by the rise of the world's Chinese medicine fever.
Since then, the annual export value of Chinese medicine has increased from less than 2 million yuan ($293,000) to more than 20 million yuan.
Many companies from African countries have actively contacted Taiji Group to seek cooperation in the introduction of Chinese medicine to Africa.
'Heatstroke and other symptoms such as stomach upset are very common in Africa. They believe that Chinese medicines that can alleviate these symptoms will be very popular in Africa.' Wang Tao said.
Taiji Group's key variety 'Yuxiang Zhengqi Liquid' is an oral liquid medicine for the treatment of various discomforts caused by summer heat, such as acute headache, vomiting, diarrhea and abdominal pain. Huoxiangzhengqi is now registered and Exported to 5 Southeast Asian countries including Thailand and Malaysia.
The variety is about to enter seven other countries, including the Philippines, India and Pakistan.
Victor Liew, founder of PT.Sky One Health., said that in the traditional Chinese medicine market in Southeast Asia, the demand for Chinese medicine is far from being met. The company is engaged in the import and sale of Chinese patented drugs.
Liew said: 'Because the demand for Chinese medicine in the Southeast Asian market is huge, the company's income is also rising.' But he declined to disclose the company's annual income and growth rate.
Tianyi Company in Indonesia proxy More than 30 Chinese patented drugs, all imported from China's major pharmaceutical companies, including the revised pharmaceutical group, Taiji Group and Sunflower Pharmaceuticals. In addition, there are more than 10 drugs in the registration process.
Liew said that since the company was founded in 2010, there has never been an overstock problem. In 2017, the company paid a total of 20 million US dollars to Chinese pharmaceutical companies for importing Chinese patented drugs.
Tianyi's customers are from pharmacies across Indonesia. The company also sells drugs through more than 50 online shopping platforms.
Liew said that the most popular varieties include boosting immunity, reducing diseases such as stomach problems and alleviating the symptoms of common heatstroke in the tropics, or improving sleep quality.
Since ancient times, Chinese immigrants and their descendants have contributed to the promotion of Chinese medicine. Therefore, many local people believe in traditional Chinese medicine, and believe that there are fewer side effects in the treatment of ancient medicine than Western medicine. Liew said this.
There are many Chinese medicine practitioners in this area, and imported Chinese patent medicines are particularly popular because they are produced according to long-standing and widely used prescriptions.
Liew also said that it is difficult to produce these drugs locally because of the lack of access to the formula and raw materials of the drugs, which also promoted the unanimous welcome of imported Chinese patented drugs.
However, although overseas consumers are becoming more interested in Chinese medicine, only three of the many proprietary Chinese medicines produced by Chinese pharmaceutical companies are currently included in the EU.
In the United States, although there are currently more than a dozen Chinese patent medicines being clinically tested, the Chinese patent medicines successfully registered in the name of drugs have not achieved zero breakthroughs, said Yu Zhibin, director of the Chinese Medicine Department of the Chamber of Commerce.
Among the Chinese medicine export projects including extracts and raw materials, the export value of China's patented medicines showed the strongest rebound in 2017, an increase of 11.03% compared with 2016.
In 2017, the export value of Chinese herbal extracts increased by 4.33% year-on-year. Extracts are usually used as cosmetic And the ingredients of food supplements, usually the largest proportion of Chinese medicine exports.